Vanguard Investments Australia »

Legend Biotech 2 Adr Rep Ord shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-03-31 $238k 13k 18.09

More positions owned by Vanguard Investments Australia

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Investments Australia

Top funds holding Legend Biotech 2 Adr Rep Ord

FMR
Deerfield Management Company
Suvretta Capital Management
Hillhouse Capital Advisors
Westfield Capital Management Company
BlackRock
Point72 Asset Management
First Beijing Investment
Artisan Partners Limited Partnership
Two Sigma Investments
Kynam Capital Management
Acadian Asset Management
State Street Corporation
Goldman Sachs Group
Davern Capital Partners

View all funds holding Legend Biotech 2 Adr Rep Ord